(function(doc, html, url) { var widget = doc.createElement("div"); widget.innerHTML = html; var script = doc.currentScript; // e = a.currentScript; if (!script) { var scripts = doc.scripts; for (var i = 0; i < scripts.length; ++i) { script = scripts[i]; if (script.src && script.src.indexOf(url) != -1) break; } } script.parentElement.replaceChild(widget, script); }(document, '

Expanding the Clinical Spectrum of IgLON5-Syndrome

What is it about?

IgLON5-Syndrome is a recently known antibody-mediated disease that was originally associated with sleep-related disturbancies and central symptom like parkinsonism, chorea and limb ataxia. We describe the first case of a patient with IgLON5-syndrome and generalized neuromyotonia, resembling a peripheral involvement in this previously described mainly central disease.

Why is it important?

This case illustrates the expanding clinical spectrum of IgLON5-syndrome. Besides his central symptoms, this patient had signs for peripheral involvement with neuromyotonic discharges, muscle weakness and wasting, suggesting an affection of the second motor neuron or peripheral nerve.

Read more on Kudos…
The following have contributed to this page:
Stephan Wenninger
' ,"url"));